NCT06555211

Brief Summary

This randomized crossover study aims to validate measurements of renal perfusion in healthy males with PET/CT, using 15-oxygen labeled water as tracer, against the validated multiparametric MRI technique. The study will determine:

  • Total renal blood flow and regional renal perfusion at baseline (rest) and during isometric muscle exercise of the upper arm, using PET/CT (with 15-oxygen labeled water as a tracer) and MRI.
  • The coefficient of variation of renal blood flow and regional renal perfusion measurements at baseline and during isometric muscle exercise of the upper arm, using PET/CT (with 15-oxygen labeled water as a tracer) and MRI.
  • Regional renal oxygenation and oxygen extraction at baseline and during isometric muscle exercise of the upper arm using MRI.
  • The coefficient of variation on regional renal oxygenation and oxygen extraction measurements at baseline and during isometric muscle exercise of the upper arm using MRI.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 7, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 7, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 15, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

August 15, 2024

Status Verified

August 1, 2024

Enrollment Period

7 months

First QC Date

August 7, 2024

Last Update Submit

August 12, 2024

Conditions

Keywords

Total renal blood flowRegional renal perfusionRegional renal oxygenationRenal oxygen extraction

Outcome Measures

Primary Outcomes (6)

  • Coefficient of variation on total blood flow and regional renal perfusion measurements at rest and during isometric muscle exercise, measured by PET/CT with 15-Oxygen labeled water and MRI

    No metric unit

    Each participant's study day during the span of the study (approximately 5 months)

  • Total blood flow at rest and during isometric muscle exercise measured by PET/CT with 15-Oxygen labeled water and MRI

    Volume of blood pr unit time, ml/min

    Each participant's study day during the span of the study (approximately 5 months)

  • Regional renal perfusion at rest and during isometric muscle exercise measured by PET/CT with 15-Oxygen labeled water and MRI

    Volume of blood pr unit time pr unit tissue mass, ml/min/g

    Each participant's study day during the span of the study (approximately 5 months)

  • Regional renal oxygenation at rest and during isometric muscle exercise using MRI

    Percentage, fraction

    Each participant's study day during the span of the study (approximately 5 months)

  • Regional renal extraction of oxygen at rest and during isometric muscle exercise using MRI

    Percentage, fraction

    Each participant's study day during the span of the study (approximately 5 months)

  • Coefficient of variation on regional renal oxygenation and extraction of oxygen measurements at rest and isometric muscle exercise using MRI

    No metric unit

    Each participant's study day during the span of the study (approximately 5 months)

Study Arms (2)

Group randomized to begin with MRI

OTHER

Group is randomized to begin with MRI and have PET/CT performed later on the same day

Procedure: MRIProcedure: PET/CT

Group randomized to begin with PET/CT

OTHER

Group is randomized to begin with PET/CT and have MRI performed later on the same day

Procedure: MRIProcedure: PET/CT

Interventions

MRIPROCEDURE

MRI will be performed

Group randomized to begin with MRIGroup randomized to begin with PET/CT
PET/CTPROCEDURE

PET/CT will be performed

Group randomized to begin with MRIGroup randomized to begin with PET/CT

Eligibility Criteria

Age18 Years - 60 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Normal health stated through medical questionnaire, examination and blood samples.

You may not qualify if:

  • Immunosuppressive treatment
  • Alcohol abuse
  • Treatment with glucocorticoids, Glucagon-like peptide-1 (GLP-1) agonists, dipeptidyl peptidase 4 (DPP-4)-inhibitors
  • Medical treatment affecting insulin secretion or cardiovascular endpoints
  • Liver disease
  • Decreased kidney function
  • Severe claustrophobia
  • Elements incompatible with MR.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bispebjerg Hospital, Department of Clinical Physiology & Nuclear Medicine

Copenhagen, Capital Region, 2400, Denmark

RECRUITING

Study Officials

  • Ali Asmar, MD, PhD

    Bispebjerg Hospital, Department of Clinical Physiology and Nuclear Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Peter Sørensen, MD

CONTACT

Ali Asmar, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Each participant will undergo intervention, which is PET/CT, and control, which is MRI. Each participant will have both intervention and control performed the same day in randomized order.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Physician, Associate Professor

Study Record Dates

First Submitted

August 7, 2024

First Posted

August 15, 2024

Study Start

May 7, 2024

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

August 15, 2024

Record last verified: 2024-08

Locations